Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
China · Delayed Price · Currency is CNY 12.21
-0.40 (-3.17%)
Jun 18, 2026, 3:04 PM CST
SHE:300122 Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, SHE:300122 stock has a consensus rating of "Hold" and an average price target of ¥21.90. The average 1-year stock price forecast is 79.36% higher than the current stock price, while the lowest is ¥14.00 (+14.66%) and the highest is ¥32.00 (+162.08%).
Price Target: ¥21.90 (+79.36%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for SHE:300122 stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 3 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 7 | 7 | 6 | 5 | 5 | 5 |
Financial Forecast
Revenue This Year
8.41B
from 8.96B
Decreased by -6.17%
Revenue Next Year
8.98B
from 8.41B
Increased by 6.85%
EPS This Year
1.51
from -6.16
EPS Next Year
n/a
from 1.51
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.6B | ||
| Avg | 8.4B | ||
| Low | 7.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.3% | ||
| Avg | -6.2% | ||
| Low | -18.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 1.51 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |